Global Amifostine Market Market

Amifostine Market Comprehensive Study by Application (Ovarian Cancer Adjuvant Therapy, Head and Neck Cancer Adjuvant Therapy, Others), Distribution Channel (Online, Offline), Type of Drug (Tablet, Capsule, Syrup, Cream, Gel, Ointment, Liquid or Injection) Players and Region - Global Market Outlook to 2028

Amifostine Market Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Amifostine Market
Amifostine (Ethiofos) is a cytoprotective adjuvant utilized in malignancy chemotherapy and radiotherapy including DNA-restricting chemotherapeutic specialists. It is promoted by Clinigen under the business trademark Ethyol. Amifostine is supportive of medication which is actuated to the free thiol metabolite at the tissue site. The thiol metabolite is liable for the majority of the cytoprotective and radioprotective properties of amifostine and subsequently making the market to develop more in this season of the pandemic circumstance. The success of these strategies will depend on various factors, including regulatory approvals, clinical trial outcomes, and market dynamics. However, by focusing on expanding applications, improving affordability, enhancing awareness, and addressing safety concerns, the Amifostine market has the potential to significantly improve the lives of cancer patients and those facing radiation-induced side effects.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies Analyst at AMA Research estimates that United Kingdom Players will contribute the maximum growth to Global Amifostine Market market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Clinigen Group (United Kingdom), Sun Pharmaceutical (India), Taj Pharmaceuticals (India), Merro Pharmaceutical (China), Luye Pharma (China), Mingren Pharma (China), VHB Lifesciences Inc.(India) and Miracalus Pharma Private Limited (India) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Fulford India Ltd. (India), Shantha Biotechnics Limited (India), Fresenius Kabi (Germany), Teva Pharmaceutical Industries (Israel) and Accord Healthcare (India).

Segmentation Overview
AMA Research has segmented the market of Global Amifostine Market market by , Application (Ovarian Cancer Adjuvant Therapy, Head and Neck Cancer Adjuvant Therapy and Others) and Region.



On the basis of geography, the market of Amifostine Market has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Online will boost the Amifostine Market market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Type of Drug, the sub-segment i.e. Tablet will boost the Amifostine Market market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Adoption of new Chemicals in these Drugs

Market Growth Drivers:
Increasing Prevalence of Cancer Diseases Across the World is Rising the Market and Cumulative Chemotherapy in Cancer Treatment is also Enhancing the Market

Challenges:
Concern Related Towards the Side Effects and Concern Related Towards the Allergies

Restraints:
Stringent Rules by the Government and High Cost Associated with these Drugs

Opportunities:
Rising Healthcare Sector Across the World and Growing Cancer Treatment with Specified Treatment Drugs

Market Leaders and their expansionary development strategies
In October 2023, Varian and Elekta two leading radiation therapy equipment manufacturers partnered to develop and share clinical data on new treatment protocols, potentially improving the effectiveness of radiation therapy alongside Amifostine usage.
In October 2023, Oncology Research Centre (ORC) published research findings in a leading medical journal, demonstrating the potential of Amifostine to reduce cognitive decline in cancer patients undergoing radiotherapy. This opens up new avenues for exploring Amifostine's applications beyond its established uses.
A radiation countermeasure that can be used prior to radiation exposure to protect the population from the harmful effects of radiation exposure remains a major unmet medical need and is recognized as an important area for research. Despite substantial advances in the research and development for finding non-toxic, safe, and effective prophylactic countermeasures for the acute radiation syndrome (ARS), no such agent has been approved by the United States Food and Drug Administration (FDA). Thus, the FDA has approved amifostine for limited clinical indications, but not for non-clinical uses.

Key Target Audience
Manufacturers, Suppliers, Wholesalers, Distributors, and Retailers, Governmental bodies and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Ovarian Cancer Adjuvant Therapy
  • Head and Neck Cancer Adjuvant Therapy
  • Others
By Distribution Channel
  • Online
  • Offline

By Type of Drug
  • Tablet
  • Capsule
  • Syrup
  • Cream
  • Gel
  • Ointment
  • Liquid or Injection

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Prevalence of Cancer Diseases Across the World is Rising the Market
      • 3.2.2. Cumulative Chemotherapy in Cancer Treatment is also Enhancing the Market
    • 3.3. Market Challenges
      • 3.3.1. Concern Related Towards the Side Effects
      • 3.3.2. Concern Related Towards the Allergies
    • 3.4. Market Trends
      • 3.4.1. Adoption of new Chemicals in these Drugs
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Amifostine Market, by Application, Distribution Channel, Type of Drug and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Amifostine Market (Value)
      • 5.2.1. Global Amifostine Market by: Application (Value)
        • 5.2.1.1. Ovarian Cancer Adjuvant Therapy
        • 5.2.1.2. Head and Neck Cancer Adjuvant Therapy
        • 5.2.1.3. Others
      • 5.2.2. Global Amifostine Market by: Distribution Channel (Value)
        • 5.2.2.1. Online
        • 5.2.2.2. Offline
      • 5.2.3. Global Amifostine Market by: Type of Drug (Value)
        • 5.2.3.1. Tablet
        • 5.2.3.2. Capsule
        • 5.2.3.3. Syrup
        • 5.2.3.4. Cream
        • 5.2.3.5. Gel
        • 5.2.3.6. Ointment
        • 5.2.3.7. Liquid or Injection
      • 5.2.4. Global Amifostine Market Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Amifostine Market (Volume)
      • 5.3.1. Global Amifostine Market by: Application (Volume)
        • 5.3.1.1. Ovarian Cancer Adjuvant Therapy
        • 5.3.1.2. Head and Neck Cancer Adjuvant Therapy
        • 5.3.1.3. Others
      • 5.3.2. Global Amifostine Market by: Distribution Channel (Volume)
        • 5.3.2.1. Online
        • 5.3.2.2. Offline
      • 5.3.3. Global Amifostine Market by: Type of Drug (Volume)
        • 5.3.3.1. Tablet
        • 5.3.3.2. Capsule
        • 5.3.3.3. Syrup
        • 5.3.3.4. Cream
        • 5.3.3.5. Gel
        • 5.3.3.6. Ointment
        • 5.3.3.7. Liquid or Injection
      • 5.3.4. Global Amifostine Market Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Amifostine Market (Price)
  • 6. Amifostine Market: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Clinigen Group (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Sun Pharmaceutical (India)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Taj Pharmaceuticals (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Merro Pharmaceutical (China)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Luye Pharma (China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Mingren Pharma (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. VHB Lifesciences Inc.(India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Miracalus Pharma Private Limited (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Amifostine Market Sale, by Application, Distribution Channel, Type of Drug and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Amifostine Market (Value)
      • 7.2.1. Global Amifostine Market by: Application (Value)
        • 7.2.1.1. Ovarian Cancer Adjuvant Therapy
        • 7.2.1.2. Head and Neck Cancer Adjuvant Therapy
        • 7.2.1.3. Others
      • 7.2.2. Global Amifostine Market by: Distribution Channel (Value)
        • 7.2.2.1. Online
        • 7.2.2.2. Offline
      • 7.2.3. Global Amifostine Market by: Type of Drug (Value)
        • 7.2.3.1. Tablet
        • 7.2.3.2. Capsule
        • 7.2.3.3. Syrup
        • 7.2.3.4. Cream
        • 7.2.3.5. Gel
        • 7.2.3.6. Ointment
        • 7.2.3.7. Liquid or Injection
      • 7.2.4. Global Amifostine Market Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Amifostine Market (Volume)
      • 7.3.1. Global Amifostine Market by: Application (Volume)
        • 7.3.1.1. Ovarian Cancer Adjuvant Therapy
        • 7.3.1.2. Head and Neck Cancer Adjuvant Therapy
        • 7.3.1.3. Others
      • 7.3.2. Global Amifostine Market by: Distribution Channel (Volume)
        • 7.3.2.1. Online
        • 7.3.2.2. Offline
      • 7.3.3. Global Amifostine Market by: Type of Drug (Volume)
        • 7.3.3.1. Tablet
        • 7.3.3.2. Capsule
        • 7.3.3.3. Syrup
        • 7.3.3.4. Cream
        • 7.3.3.5. Gel
        • 7.3.3.6. Ointment
        • 7.3.3.7. Liquid or Injection
      • 7.3.4. Global Amifostine Market Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Amifostine Market (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Amifostine Market: by Application(USD Million)
  • Table 2. Amifostine Market Ovarian Cancer Adjuvant Therapy , by Region USD Million (2017-2022)
  • Table 3. Amifostine Market Head and Neck Cancer Adjuvant Therapy , by Region USD Million (2017-2022)
  • Table 4. Amifostine Market Others , by Region USD Million (2017-2022)
  • Table 5. Amifostine Market: by Distribution Channel(USD Million)
  • Table 6. Amifostine Market Online , by Region USD Million (2017-2022)
  • Table 7. Amifostine Market Offline , by Region USD Million (2017-2022)
  • Table 8. Amifostine Market: by Type of Drug(USD Million)
  • Table 9. Amifostine Market Tablet , by Region USD Million (2017-2022)
  • Table 10. Amifostine Market Capsule , by Region USD Million (2017-2022)
  • Table 11. Amifostine Market Syrup , by Region USD Million (2017-2022)
  • Table 12. Amifostine Market Cream , by Region USD Million (2017-2022)
  • Table 13. Amifostine Market Gel , by Region USD Million (2017-2022)
  • Table 14. Amifostine Market Ointment , by Region USD Million (2017-2022)
  • Table 15. Amifostine Market Liquid or Injection , by Region USD Million (2017-2022)
  • Table 16. South America Amifostine Market, by Country USD Million (2017-2022)
  • Table 17. South America Amifostine Market, by Application USD Million (2017-2022)
  • Table 18. South America Amifostine Market, by Distribution Channel USD Million (2017-2022)
  • Table 19. South America Amifostine Market, by Type of Drug USD Million (2017-2022)
  • Table 20. Brazil Amifostine Market, by Application USD Million (2017-2022)
  • Table 21. Brazil Amifostine Market, by Distribution Channel USD Million (2017-2022)
  • Table 22. Brazil Amifostine Market, by Type of Drug USD Million (2017-2022)
  • Table 23. Argentina Amifostine Market, by Application USD Million (2017-2022)
  • Table 24. Argentina Amifostine Market, by Distribution Channel USD Million (2017-2022)
  • Table 25. Argentina Amifostine Market, by Type of Drug USD Million (2017-2022)
  • Table 26. Rest of South America Amifostine Market, by Application USD Million (2017-2022)
  • Table 27. Rest of South America Amifostine Market, by Distribution Channel USD Million (2017-2022)
  • Table 28. Rest of South America Amifostine Market, by Type of Drug USD Million (2017-2022)
  • Table 29. Asia Pacific Amifostine Market, by Country USD Million (2017-2022)
  • Table 30. Asia Pacific Amifostine Market, by Application USD Million (2017-2022)
  • Table 31. Asia Pacific Amifostine Market, by Distribution Channel USD Million (2017-2022)
  • Table 32. Asia Pacific Amifostine Market, by Type of Drug USD Million (2017-2022)
  • Table 33. China Amifostine Market, by Application USD Million (2017-2022)
  • Table 34. China Amifostine Market, by Distribution Channel USD Million (2017-2022)
  • Table 35. China Amifostine Market, by Type of Drug USD Million (2017-2022)
  • Table 36. Japan Amifostine Market, by Application USD Million (2017-2022)
  • Table 37. Japan Amifostine Market, by Distribution Channel USD Million (2017-2022)
  • Table 38. Japan Amifostine Market, by Type of Drug USD Million (2017-2022)
  • Table 39. India Amifostine Market, by Application USD Million (2017-2022)
  • Table 40. India Amifostine Market, by Distribution Channel USD Million (2017-2022)
  • Table 41. India Amifostine Market, by Type of Drug USD Million (2017-2022)
  • Table 42. South Korea Amifostine Market, by Application USD Million (2017-2022)
  • Table 43. South Korea Amifostine Market, by Distribution Channel USD Million (2017-2022)
  • Table 44. South Korea Amifostine Market, by Type of Drug USD Million (2017-2022)
  • Table 45. Taiwan Amifostine Market, by Application USD Million (2017-2022)
  • Table 46. Taiwan Amifostine Market, by Distribution Channel USD Million (2017-2022)
  • Table 47. Taiwan Amifostine Market, by Type of Drug USD Million (2017-2022)
  • Table 48. Australia Amifostine Market, by Application USD Million (2017-2022)
  • Table 49. Australia Amifostine Market, by Distribution Channel USD Million (2017-2022)
  • Table 50. Australia Amifostine Market, by Type of Drug USD Million (2017-2022)
  • Table 51. Rest of Asia-Pacific Amifostine Market, by Application USD Million (2017-2022)
  • Table 52. Rest of Asia-Pacific Amifostine Market, by Distribution Channel USD Million (2017-2022)
  • Table 53. Rest of Asia-Pacific Amifostine Market, by Type of Drug USD Million (2017-2022)
  • Table 54. Europe Amifostine Market, by Country USD Million (2017-2022)
  • Table 55. Europe Amifostine Market, by Application USD Million (2017-2022)
  • Table 56. Europe Amifostine Market, by Distribution Channel USD Million (2017-2022)
  • Table 57. Europe Amifostine Market, by Type of Drug USD Million (2017-2022)
  • Table 58. Germany Amifostine Market, by Application USD Million (2017-2022)
  • Table 59. Germany Amifostine Market, by Distribution Channel USD Million (2017-2022)
  • Table 60. Germany Amifostine Market, by Type of Drug USD Million (2017-2022)
  • Table 61. France Amifostine Market, by Application USD Million (2017-2022)
  • Table 62. France Amifostine Market, by Distribution Channel USD Million (2017-2022)
  • Table 63. France Amifostine Market, by Type of Drug USD Million (2017-2022)
  • Table 64. Italy Amifostine Market, by Application USD Million (2017-2022)
  • Table 65. Italy Amifostine Market, by Distribution Channel USD Million (2017-2022)
  • Table 66. Italy Amifostine Market, by Type of Drug USD Million (2017-2022)
  • Table 67. United Kingdom Amifostine Market, by Application USD Million (2017-2022)
  • Table 68. United Kingdom Amifostine Market, by Distribution Channel USD Million (2017-2022)
  • Table 69. United Kingdom Amifostine Market, by Type of Drug USD Million (2017-2022)
  • Table 70. Netherlands Amifostine Market, by Application USD Million (2017-2022)
  • Table 71. Netherlands Amifostine Market, by Distribution Channel USD Million (2017-2022)
  • Table 72. Netherlands Amifostine Market, by Type of Drug USD Million (2017-2022)
  • Table 73. Rest of Europe Amifostine Market, by Application USD Million (2017-2022)
  • Table 74. Rest of Europe Amifostine Market, by Distribution Channel USD Million (2017-2022)
  • Table 75. Rest of Europe Amifostine Market, by Type of Drug USD Million (2017-2022)
  • Table 76. MEA Amifostine Market, by Country USD Million (2017-2022)
  • Table 77. MEA Amifostine Market, by Application USD Million (2017-2022)
  • Table 78. MEA Amifostine Market, by Distribution Channel USD Million (2017-2022)
  • Table 79. MEA Amifostine Market, by Type of Drug USD Million (2017-2022)
  • Table 80. Middle East Amifostine Market, by Application USD Million (2017-2022)
  • Table 81. Middle East Amifostine Market, by Distribution Channel USD Million (2017-2022)
  • Table 82. Middle East Amifostine Market, by Type of Drug USD Million (2017-2022)
  • Table 83. Africa Amifostine Market, by Application USD Million (2017-2022)
  • Table 84. Africa Amifostine Market, by Distribution Channel USD Million (2017-2022)
  • Table 85. Africa Amifostine Market, by Type of Drug USD Million (2017-2022)
  • Table 86. North America Amifostine Market, by Country USD Million (2017-2022)
  • Table 87. North America Amifostine Market, by Application USD Million (2017-2022)
  • Table 88. North America Amifostine Market, by Distribution Channel USD Million (2017-2022)
  • Table 89. North America Amifostine Market, by Type of Drug USD Million (2017-2022)
  • Table 90. United States Amifostine Market, by Application USD Million (2017-2022)
  • Table 91. United States Amifostine Market, by Distribution Channel USD Million (2017-2022)
  • Table 92. United States Amifostine Market, by Type of Drug USD Million (2017-2022)
  • Table 93. Canada Amifostine Market, by Application USD Million (2017-2022)
  • Table 94. Canada Amifostine Market, by Distribution Channel USD Million (2017-2022)
  • Table 95. Canada Amifostine Market, by Type of Drug USD Million (2017-2022)
  • Table 96. Mexico Amifostine Market, by Application USD Million (2017-2022)
  • Table 97. Mexico Amifostine Market, by Distribution Channel USD Million (2017-2022)
  • Table 98. Mexico Amifostine Market, by Type of Drug USD Million (2017-2022)
  • Table 99. Amifostine Market Sales: by Application(UNIT)
  • Table 100. Amifostine Market Sales Ovarian Cancer Adjuvant Therapy , by Region UNIT (2017-2022)
  • Table 101. Amifostine Market Sales Head and Neck Cancer Adjuvant Therapy , by Region UNIT (2017-2022)
  • Table 102. Amifostine Market Sales Others , by Region UNIT (2017-2022)
  • Table 103. Amifostine Market Sales: by Distribution Channel(UNIT)
  • Table 104. Amifostine Market Sales Online , by Region UNIT (2017-2022)
  • Table 105. Amifostine Market Sales Offline , by Region UNIT (2017-2022)
  • Table 106. Amifostine Market Sales: by Type of Drug(UNIT)
  • Table 107. Amifostine Market Sales Tablet , by Region UNIT (2017-2022)
  • Table 108. Amifostine Market Sales Capsule , by Region UNIT (2017-2022)
  • Table 109. Amifostine Market Sales Syrup , by Region UNIT (2017-2022)
  • Table 110. Amifostine Market Sales Cream , by Region UNIT (2017-2022)
  • Table 111. Amifostine Market Sales Gel , by Region UNIT (2017-2022)
  • Table 112. Amifostine Market Sales Ointment , by Region UNIT (2017-2022)
  • Table 113. Amifostine Market Sales Liquid or Injection , by Region UNIT (2017-2022)
  • Table 114. South America Amifostine Market Sales, by Country UNIT (2017-2022)
  • Table 115. South America Amifostine Market Sales, by Application UNIT (2017-2022)
  • Table 116. South America Amifostine Market Sales, by Distribution Channel UNIT (2017-2022)
  • Table 117. South America Amifostine Market Sales, by Type of Drug UNIT (2017-2022)
  • Table 118. Brazil Amifostine Market Sales, by Application UNIT (2017-2022)
  • Table 119. Brazil Amifostine Market Sales, by Distribution Channel UNIT (2017-2022)
  • Table 120. Brazil Amifostine Market Sales, by Type of Drug UNIT (2017-2022)
  • Table 121. Argentina Amifostine Market Sales, by Application UNIT (2017-2022)
  • Table 122. Argentina Amifostine Market Sales, by Distribution Channel UNIT (2017-2022)
  • Table 123. Argentina Amifostine Market Sales, by Type of Drug UNIT (2017-2022)
  • Table 124. Rest of South America Amifostine Market Sales, by Application UNIT (2017-2022)
  • Table 125. Rest of South America Amifostine Market Sales, by Distribution Channel UNIT (2017-2022)
  • Table 126. Rest of South America Amifostine Market Sales, by Type of Drug UNIT (2017-2022)
  • Table 127. Asia Pacific Amifostine Market Sales, by Country UNIT (2017-2022)
  • Table 128. Asia Pacific Amifostine Market Sales, by Application UNIT (2017-2022)
  • Table 129. Asia Pacific Amifostine Market Sales, by Distribution Channel UNIT (2017-2022)
  • Table 130. Asia Pacific Amifostine Market Sales, by Type of Drug UNIT (2017-2022)
  • Table 131. China Amifostine Market Sales, by Application UNIT (2017-2022)
  • Table 132. China Amifostine Market Sales, by Distribution Channel UNIT (2017-2022)
  • Table 133. China Amifostine Market Sales, by Type of Drug UNIT (2017-2022)
  • Table 134. Japan Amifostine Market Sales, by Application UNIT (2017-2022)
  • Table 135. Japan Amifostine Market Sales, by Distribution Channel UNIT (2017-2022)
  • Table 136. Japan Amifostine Market Sales, by Type of Drug UNIT (2017-2022)
  • Table 137. India Amifostine Market Sales, by Application UNIT (2017-2022)
  • Table 138. India Amifostine Market Sales, by Distribution Channel UNIT (2017-2022)
  • Table 139. India Amifostine Market Sales, by Type of Drug UNIT (2017-2022)
  • Table 140. South Korea Amifostine Market Sales, by Application UNIT (2017-2022)
  • Table 141. South Korea Amifostine Market Sales, by Distribution Channel UNIT (2017-2022)
  • Table 142. South Korea Amifostine Market Sales, by Type of Drug UNIT (2017-2022)
  • Table 143. Taiwan Amifostine Market Sales, by Application UNIT (2017-2022)
  • Table 144. Taiwan Amifostine Market Sales, by Distribution Channel UNIT (2017-2022)
  • Table 145. Taiwan Amifostine Market Sales, by Type of Drug UNIT (2017-2022)
  • Table 146. Australia Amifostine Market Sales, by Application UNIT (2017-2022)
  • Table 147. Australia Amifostine Market Sales, by Distribution Channel UNIT (2017-2022)
  • Table 148. Australia Amifostine Market Sales, by Type of Drug UNIT (2017-2022)
  • Table 149. Rest of Asia-Pacific Amifostine Market Sales, by Application UNIT (2017-2022)
  • Table 150. Rest of Asia-Pacific Amifostine Market Sales, by Distribution Channel UNIT (2017-2022)
  • Table 151. Rest of Asia-Pacific Amifostine Market Sales, by Type of Drug UNIT (2017-2022)
  • Table 152. Europe Amifostine Market Sales, by Country UNIT (2017-2022)
  • Table 153. Europe Amifostine Market Sales, by Application UNIT (2017-2022)
  • Table 154. Europe Amifostine Market Sales, by Distribution Channel UNIT (2017-2022)
  • Table 155. Europe Amifostine Market Sales, by Type of Drug UNIT (2017-2022)
  • Table 156. Germany Amifostine Market Sales, by Application UNIT (2017-2022)
  • Table 157. Germany Amifostine Market Sales, by Distribution Channel UNIT (2017-2022)
  • Table 158. Germany Amifostine Market Sales, by Type of Drug UNIT (2017-2022)
  • Table 159. France Amifostine Market Sales, by Application UNIT (2017-2022)
  • Table 160. France Amifostine Market Sales, by Distribution Channel UNIT (2017-2022)
  • Table 161. France Amifostine Market Sales, by Type of Drug UNIT (2017-2022)
  • Table 162. Italy Amifostine Market Sales, by Application UNIT (2017-2022)
  • Table 163. Italy Amifostine Market Sales, by Distribution Channel UNIT (2017-2022)
  • Table 164. Italy Amifostine Market Sales, by Type of Drug UNIT (2017-2022)
  • Table 165. United Kingdom Amifostine Market Sales, by Application UNIT (2017-2022)
  • Table 166. United Kingdom Amifostine Market Sales, by Distribution Channel UNIT (2017-2022)
  • Table 167. United Kingdom Amifostine Market Sales, by Type of Drug UNIT (2017-2022)
  • Table 168. Netherlands Amifostine Market Sales, by Application UNIT (2017-2022)
  • Table 169. Netherlands Amifostine Market Sales, by Distribution Channel UNIT (2017-2022)
  • Table 170. Netherlands Amifostine Market Sales, by Type of Drug UNIT (2017-2022)
  • Table 171. Rest of Europe Amifostine Market Sales, by Application UNIT (2017-2022)
  • Table 172. Rest of Europe Amifostine Market Sales, by Distribution Channel UNIT (2017-2022)
  • Table 173. Rest of Europe Amifostine Market Sales, by Type of Drug UNIT (2017-2022)
  • Table 174. MEA Amifostine Market Sales, by Country UNIT (2017-2022)
  • Table 175. MEA Amifostine Market Sales, by Application UNIT (2017-2022)
  • Table 176. MEA Amifostine Market Sales, by Distribution Channel UNIT (2017-2022)
  • Table 177. MEA Amifostine Market Sales, by Type of Drug UNIT (2017-2022)
  • Table 178. Middle East Amifostine Market Sales, by Application UNIT (2017-2022)
  • Table 179. Middle East Amifostine Market Sales, by Distribution Channel UNIT (2017-2022)
  • Table 180. Middle East Amifostine Market Sales, by Type of Drug UNIT (2017-2022)
  • Table 181. Africa Amifostine Market Sales, by Application UNIT (2017-2022)
  • Table 182. Africa Amifostine Market Sales, by Distribution Channel UNIT (2017-2022)
  • Table 183. Africa Amifostine Market Sales, by Type of Drug UNIT (2017-2022)
  • Table 184. North America Amifostine Market Sales, by Country UNIT (2017-2022)
  • Table 185. North America Amifostine Market Sales, by Application UNIT (2017-2022)
  • Table 186. North America Amifostine Market Sales, by Distribution Channel UNIT (2017-2022)
  • Table 187. North America Amifostine Market Sales, by Type of Drug UNIT (2017-2022)
  • Table 188. United States Amifostine Market Sales, by Application UNIT (2017-2022)
  • Table 189. United States Amifostine Market Sales, by Distribution Channel UNIT (2017-2022)
  • Table 190. United States Amifostine Market Sales, by Type of Drug UNIT (2017-2022)
  • Table 191. Canada Amifostine Market Sales, by Application UNIT (2017-2022)
  • Table 192. Canada Amifostine Market Sales, by Distribution Channel UNIT (2017-2022)
  • Table 193. Canada Amifostine Market Sales, by Type of Drug UNIT (2017-2022)
  • Table 194. Mexico Amifostine Market Sales, by Application UNIT (2017-2022)
  • Table 195. Mexico Amifostine Market Sales, by Distribution Channel UNIT (2017-2022)
  • Table 196. Mexico Amifostine Market Sales, by Type of Drug UNIT (2017-2022)
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Amifostine Market: by Application(USD Million)
  • Table 206. Amifostine Market Ovarian Cancer Adjuvant Therapy , by Region USD Million (2023-2028)
  • Table 207. Amifostine Market Head and Neck Cancer Adjuvant Therapy , by Region USD Million (2023-2028)
  • Table 208. Amifostine Market Others , by Region USD Million (2023-2028)
  • Table 209. Amifostine Market: by Distribution Channel(USD Million)
  • Table 210. Amifostine Market Online , by Region USD Million (2023-2028)
  • Table 211. Amifostine Market Offline , by Region USD Million (2023-2028)
  • Table 212. Amifostine Market: by Type of Drug(USD Million)
  • Table 213. Amifostine Market Tablet , by Region USD Million (2023-2028)
  • Table 214. Amifostine Market Capsule , by Region USD Million (2023-2028)
  • Table 215. Amifostine Market Syrup , by Region USD Million (2023-2028)
  • Table 216. Amifostine Market Cream , by Region USD Million (2023-2028)
  • Table 217. Amifostine Market Gel , by Region USD Million (2023-2028)
  • Table 218. Amifostine Market Ointment , by Region USD Million (2023-2028)
  • Table 219. Amifostine Market Liquid or Injection , by Region USD Million (2023-2028)
  • Table 220. South America Amifostine Market, by Country USD Million (2023-2028)
  • Table 221. South America Amifostine Market, by Application USD Million (2023-2028)
  • Table 222. South America Amifostine Market, by Distribution Channel USD Million (2023-2028)
  • Table 223. South America Amifostine Market, by Type of Drug USD Million (2023-2028)
  • Table 224. Brazil Amifostine Market, by Application USD Million (2023-2028)
  • Table 225. Brazil Amifostine Market, by Distribution Channel USD Million (2023-2028)
  • Table 226. Brazil Amifostine Market, by Type of Drug USD Million (2023-2028)
  • Table 227. Argentina Amifostine Market, by Application USD Million (2023-2028)
  • Table 228. Argentina Amifostine Market, by Distribution Channel USD Million (2023-2028)
  • Table 229. Argentina Amifostine Market, by Type of Drug USD Million (2023-2028)
  • Table 230. Rest of South America Amifostine Market, by Application USD Million (2023-2028)
  • Table 231. Rest of South America Amifostine Market, by Distribution Channel USD Million (2023-2028)
  • Table 232. Rest of South America Amifostine Market, by Type of Drug USD Million (2023-2028)
  • Table 233. Asia Pacific Amifostine Market, by Country USD Million (2023-2028)
  • Table 234. Asia Pacific Amifostine Market, by Application USD Million (2023-2028)
  • Table 235. Asia Pacific Amifostine Market, by Distribution Channel USD Million (2023-2028)
  • Table 236. Asia Pacific Amifostine Market, by Type of Drug USD Million (2023-2028)
  • Table 237. China Amifostine Market, by Application USD Million (2023-2028)
  • Table 238. China Amifostine Market, by Distribution Channel USD Million (2023-2028)
  • Table 239. China Amifostine Market, by Type of Drug USD Million (2023-2028)
  • Table 240. Japan Amifostine Market, by Application USD Million (2023-2028)
  • Table 241. Japan Amifostine Market, by Distribution Channel USD Million (2023-2028)
  • Table 242. Japan Amifostine Market, by Type of Drug USD Million (2023-2028)
  • Table 243. India Amifostine Market, by Application USD Million (2023-2028)
  • Table 244. India Amifostine Market, by Distribution Channel USD Million (2023-2028)
  • Table 245. India Amifostine Market, by Type of Drug USD Million (2023-2028)
  • Table 246. South Korea Amifostine Market, by Application USD Million (2023-2028)
  • Table 247. South Korea Amifostine Market, by Distribution Channel USD Million (2023-2028)
  • Table 248. South Korea Amifostine Market, by Type of Drug USD Million (2023-2028)
  • Table 249. Taiwan Amifostine Market, by Application USD Million (2023-2028)
  • Table 250. Taiwan Amifostine Market, by Distribution Channel USD Million (2023-2028)
  • Table 251. Taiwan Amifostine Market, by Type of Drug USD Million (2023-2028)
  • Table 252. Australia Amifostine Market, by Application USD Million (2023-2028)
  • Table 253. Australia Amifostine Market, by Distribution Channel USD Million (2023-2028)
  • Table 254. Australia Amifostine Market, by Type of Drug USD Million (2023-2028)
  • Table 255. Rest of Asia-Pacific Amifostine Market, by Application USD Million (2023-2028)
  • Table 256. Rest of Asia-Pacific Amifostine Market, by Distribution Channel USD Million (2023-2028)
  • Table 257. Rest of Asia-Pacific Amifostine Market, by Type of Drug USD Million (2023-2028)
  • Table 258. Europe Amifostine Market, by Country USD Million (2023-2028)
  • Table 259. Europe Amifostine Market, by Application USD Million (2023-2028)
  • Table 260. Europe Amifostine Market, by Distribution Channel USD Million (2023-2028)
  • Table 261. Europe Amifostine Market, by Type of Drug USD Million (2023-2028)
  • Table 262. Germany Amifostine Market, by Application USD Million (2023-2028)
  • Table 263. Germany Amifostine Market, by Distribution Channel USD Million (2023-2028)
  • Table 264. Germany Amifostine Market, by Type of Drug USD Million (2023-2028)
  • Table 265. France Amifostine Market, by Application USD Million (2023-2028)
  • Table 266. France Amifostine Market, by Distribution Channel USD Million (2023-2028)
  • Table 267. France Amifostine Market, by Type of Drug USD Million (2023-2028)
  • Table 268. Italy Amifostine Market, by Application USD Million (2023-2028)
  • Table 269. Italy Amifostine Market, by Distribution Channel USD Million (2023-2028)
  • Table 270. Italy Amifostine Market, by Type of Drug USD Million (2023-2028)
  • Table 271. United Kingdom Amifostine Market, by Application USD Million (2023-2028)
  • Table 272. United Kingdom Amifostine Market, by Distribution Channel USD Million (2023-2028)
  • Table 273. United Kingdom Amifostine Market, by Type of Drug USD Million (2023-2028)
  • Table 274. Netherlands Amifostine Market, by Application USD Million (2023-2028)
  • Table 275. Netherlands Amifostine Market, by Distribution Channel USD Million (2023-2028)
  • Table 276. Netherlands Amifostine Market, by Type of Drug USD Million (2023-2028)
  • Table 277. Rest of Europe Amifostine Market, by Application USD Million (2023-2028)
  • Table 278. Rest of Europe Amifostine Market, by Distribution Channel USD Million (2023-2028)
  • Table 279. Rest of Europe Amifostine Market, by Type of Drug USD Million (2023-2028)
  • Table 280. MEA Amifostine Market, by Country USD Million (2023-2028)
  • Table 281. MEA Amifostine Market, by Application USD Million (2023-2028)
  • Table 282. MEA Amifostine Market, by Distribution Channel USD Million (2023-2028)
  • Table 283. MEA Amifostine Market, by Type of Drug USD Million (2023-2028)
  • Table 284. Middle East Amifostine Market, by Application USD Million (2023-2028)
  • Table 285. Middle East Amifostine Market, by Distribution Channel USD Million (2023-2028)
  • Table 286. Middle East Amifostine Market, by Type of Drug USD Million (2023-2028)
  • Table 287. Africa Amifostine Market, by Application USD Million (2023-2028)
  • Table 288. Africa Amifostine Market, by Distribution Channel USD Million (2023-2028)
  • Table 289. Africa Amifostine Market, by Type of Drug USD Million (2023-2028)
  • Table 290. North America Amifostine Market, by Country USD Million (2023-2028)
  • Table 291. North America Amifostine Market, by Application USD Million (2023-2028)
  • Table 292. North America Amifostine Market, by Distribution Channel USD Million (2023-2028)
  • Table 293. North America Amifostine Market, by Type of Drug USD Million (2023-2028)
  • Table 294. United States Amifostine Market, by Application USD Million (2023-2028)
  • Table 295. United States Amifostine Market, by Distribution Channel USD Million (2023-2028)
  • Table 296. United States Amifostine Market, by Type of Drug USD Million (2023-2028)
  • Table 297. Canada Amifostine Market, by Application USD Million (2023-2028)
  • Table 298. Canada Amifostine Market, by Distribution Channel USD Million (2023-2028)
  • Table 299. Canada Amifostine Market, by Type of Drug USD Million (2023-2028)
  • Table 300. Mexico Amifostine Market, by Application USD Million (2023-2028)
  • Table 301. Mexico Amifostine Market, by Distribution Channel USD Million (2023-2028)
  • Table 302. Mexico Amifostine Market, by Type of Drug USD Million (2023-2028)
  • Table 303. Amifostine Market Sales: by Application(UNIT)
  • Table 304. Amifostine Market Sales Ovarian Cancer Adjuvant Therapy , by Region UNIT (2023-2028)
  • Table 305. Amifostine Market Sales Head and Neck Cancer Adjuvant Therapy , by Region UNIT (2023-2028)
  • Table 306. Amifostine Market Sales Others , by Region UNIT (2023-2028)
  • Table 307. Amifostine Market Sales: by Distribution Channel(UNIT)
  • Table 308. Amifostine Market Sales Online , by Region UNIT (2023-2028)
  • Table 309. Amifostine Market Sales Offline , by Region UNIT (2023-2028)
  • Table 310. Amifostine Market Sales: by Type of Drug(UNIT)
  • Table 311. Amifostine Market Sales Tablet , by Region UNIT (2023-2028)
  • Table 312. Amifostine Market Sales Capsule , by Region UNIT (2023-2028)
  • Table 313. Amifostine Market Sales Syrup , by Region UNIT (2023-2028)
  • Table 314. Amifostine Market Sales Cream , by Region UNIT (2023-2028)
  • Table 315. Amifostine Market Sales Gel , by Region UNIT (2023-2028)
  • Table 316. Amifostine Market Sales Ointment , by Region UNIT (2023-2028)
  • Table 317. Amifostine Market Sales Liquid or Injection , by Region UNIT (2023-2028)
  • Table 318. South America Amifostine Market Sales, by Country UNIT (2023-2028)
  • Table 319. South America Amifostine Market Sales, by Application UNIT (2023-2028)
  • Table 320. South America Amifostine Market Sales, by Distribution Channel UNIT (2023-2028)
  • Table 321. South America Amifostine Market Sales, by Type of Drug UNIT (2023-2028)
  • Table 322. Brazil Amifostine Market Sales, by Application UNIT (2023-2028)
  • Table 323. Brazil Amifostine Market Sales, by Distribution Channel UNIT (2023-2028)
  • Table 324. Brazil Amifostine Market Sales, by Type of Drug UNIT (2023-2028)
  • Table 325. Argentina Amifostine Market Sales, by Application UNIT (2023-2028)
  • Table 326. Argentina Amifostine Market Sales, by Distribution Channel UNIT (2023-2028)
  • Table 327. Argentina Amifostine Market Sales, by Type of Drug UNIT (2023-2028)
  • Table 328. Rest of South America Amifostine Market Sales, by Application UNIT (2023-2028)
  • Table 329. Rest of South America Amifostine Market Sales, by Distribution Channel UNIT (2023-2028)
  • Table 330. Rest of South America Amifostine Market Sales, by Type of Drug UNIT (2023-2028)
  • Table 331. Asia Pacific Amifostine Market Sales, by Country UNIT (2023-2028)
  • Table 332. Asia Pacific Amifostine Market Sales, by Application UNIT (2023-2028)
  • Table 333. Asia Pacific Amifostine Market Sales, by Distribution Channel UNIT (2023-2028)
  • Table 334. Asia Pacific Amifostine Market Sales, by Type of Drug UNIT (2023-2028)
  • Table 335. China Amifostine Market Sales, by Application UNIT (2023-2028)
  • Table 336. China Amifostine Market Sales, by Distribution Channel UNIT (2023-2028)
  • Table 337. China Amifostine Market Sales, by Type of Drug UNIT (2023-2028)
  • Table 338. Japan Amifostine Market Sales, by Application UNIT (2023-2028)
  • Table 339. Japan Amifostine Market Sales, by Distribution Channel UNIT (2023-2028)
  • Table 340. Japan Amifostine Market Sales, by Type of Drug UNIT (2023-2028)
  • Table 341. India Amifostine Market Sales, by Application UNIT (2023-2028)
  • Table 342. India Amifostine Market Sales, by Distribution Channel UNIT (2023-2028)
  • Table 343. India Amifostine Market Sales, by Type of Drug UNIT (2023-2028)
  • Table 344. South Korea Amifostine Market Sales, by Application UNIT (2023-2028)
  • Table 345. South Korea Amifostine Market Sales, by Distribution Channel UNIT (2023-2028)
  • Table 346. South Korea Amifostine Market Sales, by Type of Drug UNIT (2023-2028)
  • Table 347. Taiwan Amifostine Market Sales, by Application UNIT (2023-2028)
  • Table 348. Taiwan Amifostine Market Sales, by Distribution Channel UNIT (2023-2028)
  • Table 349. Taiwan Amifostine Market Sales, by Type of Drug UNIT (2023-2028)
  • Table 350. Australia Amifostine Market Sales, by Application UNIT (2023-2028)
  • Table 351. Australia Amifostine Market Sales, by Distribution Channel UNIT (2023-2028)
  • Table 352. Australia Amifostine Market Sales, by Type of Drug UNIT (2023-2028)
  • Table 353. Rest of Asia-Pacific Amifostine Market Sales, by Application UNIT (2023-2028)
  • Table 354. Rest of Asia-Pacific Amifostine Market Sales, by Distribution Channel UNIT (2023-2028)
  • Table 355. Rest of Asia-Pacific Amifostine Market Sales, by Type of Drug UNIT (2023-2028)
  • Table 356. Europe Amifostine Market Sales, by Country UNIT (2023-2028)
  • Table 357. Europe Amifostine Market Sales, by Application UNIT (2023-2028)
  • Table 358. Europe Amifostine Market Sales, by Distribution Channel UNIT (2023-2028)
  • Table 359. Europe Amifostine Market Sales, by Type of Drug UNIT (2023-2028)
  • Table 360. Germany Amifostine Market Sales, by Application UNIT (2023-2028)
  • Table 361. Germany Amifostine Market Sales, by Distribution Channel UNIT (2023-2028)
  • Table 362. Germany Amifostine Market Sales, by Type of Drug UNIT (2023-2028)
  • Table 363. France Amifostine Market Sales, by Application UNIT (2023-2028)
  • Table 364. France Amifostine Market Sales, by Distribution Channel UNIT (2023-2028)
  • Table 365. France Amifostine Market Sales, by Type of Drug UNIT (2023-2028)
  • Table 366. Italy Amifostine Market Sales, by Application UNIT (2023-2028)
  • Table 367. Italy Amifostine Market Sales, by Distribution Channel UNIT (2023-2028)
  • Table 368. Italy Amifostine Market Sales, by Type of Drug UNIT (2023-2028)
  • Table 369. United Kingdom Amifostine Market Sales, by Application UNIT (2023-2028)
  • Table 370. United Kingdom Amifostine Market Sales, by Distribution Channel UNIT (2023-2028)
  • Table 371. United Kingdom Amifostine Market Sales, by Type of Drug UNIT (2023-2028)
  • Table 372. Netherlands Amifostine Market Sales, by Application UNIT (2023-2028)
  • Table 373. Netherlands Amifostine Market Sales, by Distribution Channel UNIT (2023-2028)
  • Table 374. Netherlands Amifostine Market Sales, by Type of Drug UNIT (2023-2028)
  • Table 375. Rest of Europe Amifostine Market Sales, by Application UNIT (2023-2028)
  • Table 376. Rest of Europe Amifostine Market Sales, by Distribution Channel UNIT (2023-2028)
  • Table 377. Rest of Europe Amifostine Market Sales, by Type of Drug UNIT (2023-2028)
  • Table 378. MEA Amifostine Market Sales, by Country UNIT (2023-2028)
  • Table 379. MEA Amifostine Market Sales, by Application UNIT (2023-2028)
  • Table 380. MEA Amifostine Market Sales, by Distribution Channel UNIT (2023-2028)
  • Table 381. MEA Amifostine Market Sales, by Type of Drug UNIT (2023-2028)
  • Table 382. Middle East Amifostine Market Sales, by Application UNIT (2023-2028)
  • Table 383. Middle East Amifostine Market Sales, by Distribution Channel UNIT (2023-2028)
  • Table 384. Middle East Amifostine Market Sales, by Type of Drug UNIT (2023-2028)
  • Table 385. Africa Amifostine Market Sales, by Application UNIT (2023-2028)
  • Table 386. Africa Amifostine Market Sales, by Distribution Channel UNIT (2023-2028)
  • Table 387. Africa Amifostine Market Sales, by Type of Drug UNIT (2023-2028)
  • Table 388. North America Amifostine Market Sales, by Country UNIT (2023-2028)
  • Table 389. North America Amifostine Market Sales, by Application UNIT (2023-2028)
  • Table 390. North America Amifostine Market Sales, by Distribution Channel UNIT (2023-2028)
  • Table 391. North America Amifostine Market Sales, by Type of Drug UNIT (2023-2028)
  • Table 392. United States Amifostine Market Sales, by Application UNIT (2023-2028)
  • Table 393. United States Amifostine Market Sales, by Distribution Channel UNIT (2023-2028)
  • Table 394. United States Amifostine Market Sales, by Type of Drug UNIT (2023-2028)
  • Table 395. Canada Amifostine Market Sales, by Application UNIT (2023-2028)
  • Table 396. Canada Amifostine Market Sales, by Distribution Channel UNIT (2023-2028)
  • Table 397. Canada Amifostine Market Sales, by Type of Drug UNIT (2023-2028)
  • Table 398. Mexico Amifostine Market Sales, by Application UNIT (2023-2028)
  • Table 399. Mexico Amifostine Market Sales, by Distribution Channel UNIT (2023-2028)
  • Table 400. Mexico Amifostine Market Sales, by Type of Drug UNIT (2023-2028)
  • Table 401. Research Programs/Design for This Report
  • Table 402. Key Data Information from Secondary Sources
  • Table 403. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Amifostine Market: by Application USD Million (2017-2022)
  • Figure 5. Global Amifostine Market: by Distribution Channel USD Million (2017-2022)
  • Figure 6. Global Amifostine Market: by Type of Drug USD Million (2017-2022)
  • Figure 7. South America Amifostine Market Share (%), by Country
  • Figure 8. Asia Pacific Amifostine Market Share (%), by Country
  • Figure 9. Europe Amifostine Market Share (%), by Country
  • Figure 10. MEA Amifostine Market Share (%), by Country
  • Figure 11. North America Amifostine Market Share (%), by Country
  • Figure 12. Global Amifostine Market: by Application UNIT (2017-2022)
  • Figure 13. Global Amifostine Market: by Distribution Channel UNIT (2017-2022)
  • Figure 14. Global Amifostine Market: by Type of Drug UNIT (2017-2022)
  • Figure 15. South America Amifostine Market Share (%), by Country
  • Figure 16. Asia Pacific Amifostine Market Share (%), by Country
  • Figure 17. Europe Amifostine Market Share (%), by Country
  • Figure 18. MEA Amifostine Market Share (%), by Country
  • Figure 19. North America Amifostine Market Share (%), by Country
  • Figure 20. Global Amifostine Market share by Players 2022 (%)
  • Figure 21. Global Amifostine Market share by Players (Top 3) 2022(%)
  • Figure 22. Global Amifostine Market share by Players (Top 5) 2022(%)
  • Figure 23. BCG Matrix for key Companies
  • Figure 24. Clinigen Group (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 25. Clinigen Group (United Kingdom) Revenue: by Geography 2022
  • Figure 26. Sun Pharmaceutical (India) Revenue, Net Income and Gross profit
  • Figure 27. Sun Pharmaceutical (India) Revenue: by Geography 2022
  • Figure 28. Taj Pharmaceuticals (India) Revenue, Net Income and Gross profit
  • Figure 29. Taj Pharmaceuticals (India) Revenue: by Geography 2022
  • Figure 30. Merro Pharmaceutical (China) Revenue, Net Income and Gross profit
  • Figure 31. Merro Pharmaceutical (China) Revenue: by Geography 2022
  • Figure 32. Luye Pharma (China) Revenue, Net Income and Gross profit
  • Figure 33. Luye Pharma (China) Revenue: by Geography 2022
  • Figure 34. Mingren Pharma (China) Revenue, Net Income and Gross profit
  • Figure 35. Mingren Pharma (China) Revenue: by Geography 2022
  • Figure 36. VHB Lifesciences Inc.(India) Revenue, Net Income and Gross profit
  • Figure 37. VHB Lifesciences Inc.(India) Revenue: by Geography 2022
  • Figure 38. Miracalus Pharma Private Limited (India) Revenue, Net Income and Gross profit
  • Figure 39. Miracalus Pharma Private Limited (India) Revenue: by Geography 2022
  • Figure 40. Global Amifostine Market: by Application USD Million (2023-2028)
  • Figure 41. Global Amifostine Market: by Distribution Channel USD Million (2023-2028)
  • Figure 42. Global Amifostine Market: by Type of Drug USD Million (2023-2028)
  • Figure 43. South America Amifostine Market Share (%), by Country
  • Figure 44. Asia Pacific Amifostine Market Share (%), by Country
  • Figure 45. Europe Amifostine Market Share (%), by Country
  • Figure 46. MEA Amifostine Market Share (%), by Country
  • Figure 47. North America Amifostine Market Share (%), by Country
  • Figure 48. Global Amifostine Market: by Application UNIT (2023-2028)
  • Figure 49. Global Amifostine Market: by Distribution Channel UNIT (2023-2028)
  • Figure 50. Global Amifostine Market: by Type of Drug UNIT (2023-2028)
  • Figure 51. South America Amifostine Market Share (%), by Country
  • Figure 52. Asia Pacific Amifostine Market Share (%), by Country
  • Figure 53. Europe Amifostine Market Share (%), by Country
  • Figure 54. MEA Amifostine Market Share (%), by Country
  • Figure 55. North America Amifostine Market Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Clinigen Group (United Kingdom)
  • Sun Pharmaceutical (India)
  • Taj Pharmaceuticals (India)
  • Merro Pharmaceutical (China)
  • Luye Pharma (China)
  • Mingren Pharma (China)
  • VHB Lifesciences Inc.(India)
  • Miracalus Pharma Private Limited (India)
Additional players considered in the study are as follows:
Fulford India Ltd. (India) , Shantha Biotechnics Limited (India) , Fresenius Kabi (Germany) , Teva Pharmaceutical Industries (Israel) , Accord Healthcare (India)
Select User Access Type

Key Highlights of Report


Dec 2023 206 Pages 75 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Amifostine Market Market Quantitative research analysis
Global Amifostine Market Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Clinigen Group (United Kingdom), Sun Pharmaceutical (India), Taj Pharmaceuticals (India), Merro Pharmaceutical (China), Luye Pharma (China), Mingren Pharma (China), VHB Lifesciences Inc.(India) and Miracalus Pharma Private Limited (India) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Adoption of new Chemicals in these Drugs" is seen as one of major influencing trends for Amifostine Market Market during projected period 2022-2028.
The Amifostine Market market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Amifostine Market Market Report?

Have a Query? Click Here

Other Related Reports

Hormone Refractory Breast Cancer Comprehensive Study by Treatment (Hormone receptor-based therapy, Tumor markers therapy, Gene expression therapy, Gene mutation therapy), End-users (Hospitals, Clinic...
$ 3450
Refsum Disease Treatment Comprehensive Study by Type (Surgery Therapy, Medication), Application (Hospitals, Clinics, Others), Diagnosis (Physical, Molecular Genetic Examination, Prenatal Screening, E...
$ 3350
Trauma Care Center Comprehensive Study by Facility Type (In-house, Standalone), Trauma Type (Falls, Traffic-Related Injuries, Stab/Wound/Cut, Burn Injury, Brain Injury, Other Injuries), Service Type ...
$ 3350
Nephroblastoma Treatment Comprehensive Study by Drugs (Dactinomycin, Doxorubicin,, Vincristine, Cyclophosphamide, Etoposide), Treatment (Surgery, Chemotherapy, Radiation therapy), End-users (Hospital...
$ 3750
Staphylococcal Infection Drugs Comprehensive Study by Type (Beta-lactams, Peptides, Quinolones, Others), Application (Hospital, Pharmacy, Others), Treatment (Antibiotics, Wound Drainage, Device Remov...
$ 3450
Hepatorenal Syndrome Treatment Comprehensive Study by Type (Type 1 Hepatorenal Syndrome, Type 2 Hepatorenal Syndrome), Treatment (Therapeutics (Terlivaz, Glypressin, Lucassin, Hepatoren), Surgical Tr...
$ 3750